Latest Research Highlights the Evolving Nature of How Cancer Is Studied

June 21, 2016

The 2016 American Association for Cancer Research (AACR) Annual Meeting, was held April 16 to 20 in New Orleans, Louisiana. But it’s not too late to take a look at some of the research presented at the meeting, as it highlights the current state of cancer research and its evolving nature.

In this podcast, Apostolia-Maria Tsimberidou, MD, PhD, explains what the meeting’s theme, Delivering Cures Through Cancer Science, means for patients and discusses several highlights: share on twitter 

  • An overview of the major topics covered at the meeting, including immunotherapy, precision or personalized medicine, diagnosing cancer, and how the oncology world is evolving to bring treatments to patients sooner [2:00]

  • The combination of 2 immunotherapies, ipilimumab (Yervoy) and nivolumab (Opdivo) for the treatment of advanced melanoma [5:15]

  • Identifying and using tumor-specific genetic changes to create vaccines for cancer [15:12]

Dr. Tsimberidou is the Chair of ASCO’s Cancer Research Committee and a member of the Molecular Tumor Board for ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) study.

This is a prerecorded audio podcast, and it can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.

Share your thoughts on this blog post on Cancer.Net's Facebook and Twitter.